Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA Mutations

NCT07628504 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

420

Enrollment

OTHER

Sponsor class

Conditions

Adjuvant Drug Therapy

Interventions

DRUG: Sacituzumab Tirumotecan (sac-TMT)
DRUG: Capecitabine

Sponsor

Fudan University